By Herbert Lash NEW YORK (Reuters) – The dollar rebounded off a 15-month low and global stock markets rose on…
US FDA approves Sanofi-AstraZeneca’s preventive RSV therapy for babies
(Reuters) -The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy…
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of…
Apple stock hits record, on cusp of $3 trillion market value
By Akash Sriram and Noel Randewich (Reuters) -Apple’s stock climbed to a record high close on Wednesday and was on…
Titanic sub destroyed in ‘catastrophic implosion,’ all five aboard dead
By Joseph Ax and Steve Gorman (Reuters) -A deep-sea submersible carrying five people on a voyage to the century-old wreck…
Biden, Modi hail new era for US-India ties and tout deals
By Nandita Bose and Patricia Zengerle WASHINGTON (Reuters) -U.S. President Joe Biden and Narendra Modi hailed a new era in…
US FDA approves Sarepta’s gene therapy for rare muscular dystrophy in some kids
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
Amazon duped millions of consumers into enrolling in Prime, US FTC says
By David Shepardson WASHINGTON (Reuters) -The U.S. Federal Trade Commission on Wednesday accused Amazon.com of enrolling millions of consumers into…
Biden says threat of Putin using tactical nuclear weapons is ‘real’
By Trevor Hunnicutt and Nandita Bose (Reuters) – President Joe Biden said on Monday the threat of Russian President Vladimir…
Ukraine targets initial $40 billion for ‘Green Marshall Plan’
By Simon Jessop and Olena Harmash LONDON (Reuters) -Ukraine is seeking up to $40 billion to fund the first part…